ArticleScientific reports2026
Tibetan herbal medicine improved the health status of calves by regulating the antioxidant ability, inflammatory reaction and microbiota of female Yaks.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the effects of traditional Chinese herbal medicine compounds (TCHMCs) on gut microbiota, maternal health, and calf performance in perinatal yaks. Thirty-two yaks with expected calving dates (two months pre-calving to one month post-calving) were randomly assigned to four groups (n = 8). Groups WA, WB, and WC received normal diets supplemented with different TCHMC formulations, while group WD served as the control. High-throughput sequencing revealed that TCHMC supplementation significantly increased gut microbial diversity and altered community composition. Compared with controls, supplemented yaks exhibited higher abundances of Bacteroidetes and enrichment of short-chain fatty acid (SCFA)-producing genera, including Phascolarctobacterium, Butyricicoccus, Bulleidia, and Blautia. Potentially beneficial taxa with anti-inflammatory properties, such as Adlercreutzia, Akkermansia, Odoribacter, Dehalobacterium, and Sporosarcina, were also enriched. Calves born to treated yaks demonstrated significantly greater birth weights, reduced serum levels of pro-inflammatory cytokines (TNF-α, IL-6), and improved antioxidant capacity, as indicated by increased T-AOC and SOD activity. Among the three formulations, TCHMCⅡ (WB) exerted the most pronounced effects, enhancing microbial shifts, maternal physiological resilience, and neonatal health outcomes. In conclusion, dietary supplementation with TCHMCs during the perinatal period modulated gut microbiota, reduced maternal inflammation, strengthened antioxidant defenses, and improved calf growth performance. These findings provide new evidence supporting the use of TCHMCs as practical nutritional interventions to improve reproductive performance and offspring vitality in yak husbandry under high-altitude conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.